Search research articles
Contact Us
Filters
Showing results (441-450 of 761) with videos related to
Page
of 77
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
Mattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
Nature Reviews. Cardiology
|
August 24, 2021
Bleeding avoidance strategies in percutaneous coronary intervention
Davide Capodanno, Deepak L Bhatt, C Michael Gibson, et al.
Journal of the American Heart Association
|
February 8, 2022
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial
Davide Capodanno, Dominick J Angiolillo, Ryan J Lennon, et al.
European Heart Journal
|
February 10, 2007
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation
Raúl Moreno, Cristina Fernandez, Angel Sanchez-Recalde, et al.
European Heart Journal
|
August 31, 2010
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James, Dominick J Angiolillo, Jan H Cornel, et al.
Journal of Thrombosis and Thrombolysis
|
August 18, 2014
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists
Francesco Franchi, Jafri Syed Hammad, Fabiana Rollini, et al.
Circulation
|
August 26, 2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study
Francesco Franchi, Fabiana Rollini, Niti Aggarwal, et al.
Thrombosis and Haemostasis
|
September 18, 2024
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System
Miriam Euper, Jürgen Schreieck, Mareike Bladt, et al.
Circulation
|
October 12, 2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study
Francesco Franchi, Fabiana Rollini, Latonya Been, et al.
Circulation
|
June 20, 2024
<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association
Naveen L Pereira, Sharon Cresci, Dominick J Angiolillo, et al.
Page
of 77
Search research articles
Search
Showing results (441-450 of 761) with videos related to
Sort By:
Page
of 77
European Heart Journal. Cardiovascular Pharmacotherapy
|
May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis
Mattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
Nature Reviews. Cardiology
|
August 24, 2021
Bleeding avoidance strategies in percutaneous coronary intervention
Davide Capodanno, Deepak L Bhatt, C Michael Gibson, et al.
Journal of the American Heart Association
|
February 8, 2022
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial
Davide Capodanno, Dominick J Angiolillo, Ryan J Lennon, et al.
European Heart Journal
|
February 10, 2007
Clinical impact of in-stent late loss after drug-eluting coronary stent implantation
Raúl Moreno, Cristina Fernandez, Angel Sanchez-Recalde, et al.
European Heart Journal
|
August 31, 2010
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James, Dominick J Angiolillo, Jan H Cornel, et al.
Journal of Thrombosis and Thrombolysis
|
August 18, 2014
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists
Francesco Franchi, Jafri Syed Hammad, Fabiana Rollini, et al.
Circulation
|
August 26, 2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study
Francesco Franchi, Fabiana Rollini, Niti Aggarwal, et al.
Thrombosis and Haemostasis
|
September 18, 2024
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System
Miriam Euper, Jürgen Schreieck, Mareike Bladt, et al.
Circulation
|
October 12, 2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 Study
Francesco Franchi, Fabiana Rollini, Latonya Been, et al.
Circulation
|
June 20, 2024
<i>CYP2C19</i> Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association
Naveen L Pereira, Sharon Cresci, Dominick J Angiolillo, et al.
Page
of 77